Correction: Exosome mediated miR-155 delivery confers cisplatin chemoresistance in oral cancer cells via epithelial-mesenchymal transition
Prathibha Kirave, Piyush Gondaliya, Bhagyashri Kulkarni, Rakesh Rawal, Rachana Garg, Alok Jain, Kiran Kalia
Abstract
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsExtracellular vesicles in disease · MicroRNA in disease regulation · Silymarin and Mushroom Poisoning
This article has been corrected: In the FOXO3A blot panel (Figure 2F), the last two lines representing cis Sens +nc and cis Sens +miR-155 mimic are accidental duplicates of the last two lines representing exoRes+nc and exoRes + miR-155 mimic in the FOXO3A blot panel of Figure 4C. The actin band panel in Figure 5D accompanying the β-catenin is an accidental duplicate of the actin band panel of Figure 5B. The corrected Figures 2F and 5D, obtained using the original data, are shown below. The authors declare that these corrections do not change the results or conclusions of this paper.
Original article: Oncotarget. 2020; 11:1157–1171. 1157-1171. https://doi.org/10.18632/oncotarget.27531